Literature DB >> 31433916

Prescription Drug Monitoring Programs - Friend or Folly in Addressing the Opioid-Overdose Crisis?

Rebecca L Haffajee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31433916      PMCID： PMC7486903          DOI： 10.1056/NEJMp1904714

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review.

Authors:  Maria N Wilson; Jill A Hayden; Emily Rhodes; Alysia Robinson; Mark Asbridge
Journal:  J Pain       Date:  2019-05-03       Impact factor: 5.820

2.  Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic.

Authors:  Allison L Pitt; Keith Humphreys; Margaret L Brandeau
Journal:  Am J Public Health       Date:  2018-08-23       Impact factor: 9.308

3.  Prescription drug monitoring program design and function: A qualitative analysis.

Authors:  Lainie Rutkow; Katherine C Smith; Alden Yuanhong Lai; Jon S Vernick; Corey S Davis; G Caleb Alexander
Journal:  Drug Alcohol Depend       Date:  2017-09-28       Impact factor: 4.492

Review 4.  Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Authors:  Rebecca L Haffajee; Cecelia A French
Journal:  Curr Opin Psychol       Date:  2019-02-04

Review 5.  The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.

Authors:  Amanda I Mauri; Tarlise N Townsend; Rebecca L Haffajee
Journal:  Milbank Q       Date:  2019-12-04       Impact factor: 4.911
  5 in total
  9 in total

1.  Implementation and enforcement of state opioid prescribing laws.

Authors:  Elizabeth M Stone; Lainie Rutkow; Mark C Bicket; Colleen L Barry; G Caleb Alexander; Emma E McGinty
Journal:  Drug Alcohol Depend       Date:  2020-06-11       Impact factor: 4.492

2.  The Public Health Value of Opioid Litigation.

Authors:  Rebecca L Haffajee
Journal:  J Law Med Ethics       Date:  2020-06       Impact factor: 1.718

3.  Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application.

Authors:  Hsien-Chang Lin; Zhi Wang; Yi-Han Hu; Kosali Simon; Anne Buu
Journal:  Prev Med       Date:  2022-06-21       Impact factor: 4.637

4.  Did prescribing laws disproportionately affect opioid dispensing to Black patients?

Authors:  Tarlise N Townsend; Amy S B Bohnert; Pooja Lagisetty; Rebecca L Haffajee
Journal:  Health Serv Res       Date:  2022-03-20       Impact factor: 3.734

5.  Effect of Integrating Access to a Prescription Drug Monitoring Program Within the Electronic Health Record on the Frequency of Queries by Primary Care Clinicians: A Cluster Randomized Clinical Trial.

Authors:  Hannah T Neprash; David M Vock; Alexandra Hanson; Brent Elert; Sonja Short; Pinar Karaca-Mandic; Alexander J Rothman; Genevieve B Melton; David Satin; Rebecca Markowitz; Ezra Golberstein
Journal:  JAMA Health Forum       Date:  2022-06-05

6.  Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.

Authors:  Silvia S Martins; William Ponicki; Nathan Smith; Ariadne Rivera-Aguirre; Corey S Davis; David S Fink; Alvaro Castillo-Carniglia; Stephen G Henry; Brandon D L Marshall; Paul Gruenewald; Magdalena Cerdá
Journal:  Int J Drug Policy       Date:  2019-10-15

7.  Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019).

Authors:  Chris Delcher; Nathan Pauly; Patience Moyo
Journal:  Curr Opin Psychiatry       Date:  2020-07       Impact factor: 4.787

8.  Assessing the impact of Indiana legislation on opioid-based doctor shopping among Medicaid-enrolled pregnant women: a regression analysis.

Authors:  Sukhada S Joshi; Nicole Adams; Yuehwern Yih; Paul M Griffin
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-04-06

9.  How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use?

Authors:  Ashish Premkumar; Sedona E Speedy; Emily S Miller
Journal:  AJP Rep       Date:  2020-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.